Vnitřní lékařství 2/2026

PŘEHLEDOVÉ ČLÁNKY Hypertenze u mužů a žen | 103 / Vnitř Lék. 2026;72(2):99-103 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz 12. Izzo R, Losi MA, Stabile E et al. Development of left ventricular hypertrophy in treated hypertensive outpatients: The Campania Salute Network. Hypertension. 2017;69:136-42. Available from: <http://doi: 10.1161/HYPERTENSIONAHA.116.08158>. 13. Gerdts E, Oikarinen L, Palmieri V, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39:739-43. Available from: <http:// doi: 10.1161/hy0302.105683>. 14. Gerdts E, de Simone G. Hypertension in Women: Should There be a Sex-specific Threshold? Eur Cardiol 2021;16:e38. Available from: <http://doi: 10.15420/ecr.2021.17>. 15. Asirwatham A, Oliphant M, Kovell AC, et al. Secondary hypertension diagnosis and management among pregnant patients: a review, Am J Obstet Gynecol MFM. 2025;12:101813. Available from: <http://doi: 10.1016/j.ajogmf.2025.101813>. 16. Gorostidi M, Vinyoles E, Banegas J, et al. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res. 2015;38(1)1-7. Available from: https://doi.org/10.1038/hr.2014.149>. 17. Yin X, Paige E, Tian M, et al. The proportion of dietary salt replaced with potassium-enriched salt in the SSaSS: implications for scale-up. Hypertension. 2023;80:956-65. Available from: <http://10.1161/hypertensionaha.122.20115>. 18. Liu F, Liu Y, Sun X,et al. Race-and sex-specific association between alcohol consumption and hypertension in 22 cohort studies: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020;30(8):1249-1259. Available from: <http://doi: 10.1016/j.numecd.2020. 03. 018>. 19. Cífková R. Farmakoterapie hypertenze v těhotenství. Klin Farmakol Farm. 2023;37(2):5963. Available from: <http://doi.org/10.36290/far.2023.010>. 20. Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3(2):135142. Available from: <http://doi:10.1161/CIRCOUTCOMES.110.868307>. 21. Turnbull F, Woodward M, Neal B et al. Blood Pressure Lowering Treatment Trialists’ Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669-2680. Available from: <http://doi: 10.1093/eurheartj/ehn427>. 22. Gueyffier F, Boutitie F, Boissel JP, et al. The INDANA Investigators. The effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. Results from a meta-analysis of individual patient data randomised controlled trials. Ann Inter Med. 1997; 126(10):761-767. Available from: <http://doi: 10.7326/0003-4819-126-10-199705150-00002>. 23. Klungel OH, De Boer A, Paes AHP, et al. Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens. 1997;5(6):591600. Available from: <http://doi: 10.1097/00004872-199715060-00004>. 24. August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab. 1999; 84(6):18621866. Available from: <http://doi: 10.1210/jcem.84. 6. 5724>. 25. Lewis CE. Characteristics and treatment of hypertension in women: a review of the literature. Am J Med Sci. 1996;311(4):193-199. Available from: <http://doi: 10.1097/00000441199604000-00010>. 26. Bugiardini R, Yoon J, Kedev S, et al. Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease. Hypertension. 2020;76(3):819-826. Available from: <http://doi: 10.1161/HYPERTENSIONAHA.120.15323>. 27. Desbiens LC, Khelifi N, Wang YP, et al. Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. JBMR Plus. 2022;6(11):e10683. Available from: <http://doi: 10.1002/jbm4.10683>. 28. Arnautu AM, Nimigean VR, Nacea-Radu AC, et al. Menopausal Hormone Therapy— Risks, Benefits and Emerging Options: A Narrative Review Int. J. Mol. Sci 2025;26(22): 11098; Available from: <http://doi.org/10.3390/ijms262211098>. 29. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023;389:107-117. Available from: <http://doi: 10.1056/ NEJMoa2215025>. 30. https://www.ema.europa.eu/en/medicines/human/referrals/testosterone-containing-medicines. KNIŽNÍ NOVINKA DIA enycklopedie Tomáš Edelsberger Kniha nabízí lehce stravitelný souhrn aktuálních informací o cukrovce pro nemocné s diabetem a jejich blízké. Obsahuje více než 170 hesel, která srozumitelnou řečí vysvětlují podstatné pojmy, s nimiž se řada diabetiků během života s touto nemocí může setkat. Encyklopedie shrnuje a vysvětluje v psané i obrazové formě základy prevence, diagnostiky a léčby diabetu, jeho komplikací a nejčastějších přidružených nemocí. Cílem je umožnit se zorientovat v poměrně komplikované problematice diabetu a přispět tak k lepšímu vzájemnému porozumění mezi pacientem, lékařem a všemi dalšími, kteří pečují o jeho zdraví. Praha: Galén 2025 231 s. 155x225 mm, brožované, barevně 350 Kč, ISBN 978-80-7492-740-9 9 DIA ENCYKLOPEDIE TOMÁŠ EDELSBERGER

RkJQdWJsaXNoZXIy NDA4Mjc=